U.S. VACCINE MARKET ANALYSIS (2020-2027) - PowerPoint PPT Presentation

About This Presentation



Read here the market research report on the “U.S. Vaccine Market" published by CMI Team – PowerPoint PPT presentation

Number of Views:48


Transcript and Presenter's Notes


  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • COVID-19 Impact Tracker

  • U.S. Vaccine Market, By Product Type (Human
    Vaccine (Pediatric Vaccines, Adult Adolescent
    Vaccines, Other Human Vaccines), Animal Vaccine
    (Livestock Vaccines, Companion Animal Vaccines,
    Other Animal Vaccines)), By End User (Hospitals,
    Clinics Vaccination, Centers) - Size, Share,
    Outlook, and Opportunity Analysis, 2020 - 2027

  • A vaccine is a biological preparation that
    provides active acquired immunity to a particular
    infectious disease. Inactivated, attenuated,
    toxoid, subunit, conjugate, heterotypic,
    experimental, and valence are the types of
  • U.S. vaccines market is estimated to account
    for US 19,355.2 Mn in terms of value in 2020 and
    is estimated to account for US 27,947.4 Mn by
    the end of 2027.

U.S. Vaccines Market Drivers
  • Emergence of Covid-19 is expected to propel
    growth of the U.S. vaccines market over the
    forecast period. For instance, in the U.S. from
    January 20, 2020 to 601 pm CEST, 6 July 2020,
    there have been 2,833,552 confirmed cases of
    COVID-19 with 129,408 deaths, as reported to the
    World Health Organization.

  • Moreover, RD initiatives for new vaccines is
    also expected to aid in growth of the market. For
    instance, in March 2020, IQVIA and Quest
    Diagnostics, through its joint venture Q2
    Solutions, collaborated with the University of
    Texas Medical Branch to develop a novel assay for
    COVID-19 tests for rapid development of a
    Coronavirus vaccine.
  • Human vaccine held dominant position in the U.S.
    vaccines market in 2019, accounting
    for 81.7 share in terms of value, followed by
    animal vaccine respectively.

Figure 1. U.S. Vaccines Market Share (), by
Value, by Vaccine Type, 2019
U.S. Vaccines Market Restraints
  • High cost of refrigeration of vaccines is
    expected to hinder growth of the market. For
    vaccines, refrigeration is mandatory to prevent
    alteration of their chemical structure mainly due
    to contact with water and humidity resulting in
    ineffective medications. Maintaining this cold
    chain from production until they are used in
    treatment is a costly process accounting for
    about 80 of the price of vaccinations.
  • Moreover, short functional shelf life of certain
    vaccines is also expected to limit the market

(No Transcript)
U.S. Vaccines Market Opportunities 
  • Building registry platform and database regarding
    COVID-19 is expected to offer lucrative growth
    opportunities for players in the U.S. vaccines
    market. For instance, in April 2020, Clara
    Health, a software startup, collaborated with
    Lyft, Inc., a ridesharing company, and VSC, a
    public relations agency, to build the registry
    platform and database to connect COVID-positive
    and -negative individuals with clinical trials
    for diagnostics, treatment and vaccine discovery.

  • Moreover, initiatives to promote RD in poultry
    is also expected to aid in growth of the market. 
    For instance, in May 2020, The U.S. Poultry
    Foundation awarded a US 7,000 grant to the
    University of North Georgia to recruit students
    into the poultry science program.
  • U.S. vaccines market was valued at US 18,367.0
    Mn in 2019 and is forecast to reach a value of
    US 27,947.4 Mn by 2027 at a CAGR of 5.4 between
    2020 and 2027.

  • Figure 2. U.S. Vaccines Market Value (US Mn),
    and Y-o-Y Growth (), 2019-2027

Market Trends/Key Takeaways
  • Major players in the market are focused on
    adopting partnership and collaboration strategies
    to expand their product portfolio. For instance,
    in April 2020, Sanofi Pasteur collaborated with
    GSK to develop an adjuvanted vaccine for
  • Stringent regulations that promote vaccination
    are boosting the market growth. For instance, in
    January 2020,            the Government of New
    Jersey, U.S., mandated college students to be
    vaccinated against bacterial meningitis as a
    condition for attending an institution.

  • The Center for Biologics Evaluation and Research
    (CBER) is the central regulatory agency
    responsible for ensuring purity, safety and
    efficacy of vaccines in the U.S.

U.S. Vaccines Market Competitive Landscape
  • Major players operating in the U.S. vaccines
    market include, Sanofi Pasteur, GlaxoSmithKline
    Plc, Merck Company Incorporated, Pfizer
    Incorporated, AstraZeneca plc, and Boehringer

U.S. Vaccines Market Key Developments
  • Major players in the market are focused on
    approval and launch of new vaccines to expand
    their product portfolio. For instance, in January
    2020, Boehringer Ingelheim's U.S. Animal Health
    Business launched a vaccine, VAXXITEK HVTIBDND
    that offers protection against Marek's Disease,
    Infectious Bursal Disease (classic and variant
    types) and Newcastle Disease.
  • Similarly, in December 2019,  NewLink Genetics
    Corporation received the U.S. FDA approval for
    ERVEBO or Zaire Ebola virus vaccine V920.

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Buy Now
  • Reference https//www.coherentmarketinsights.com/

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
  • Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

  • Thank You!
  • Kindly follow CMI Social Media
    Profiles for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
Write a Comment
User Comments (0)
About PowerShow.com